Legal Representation
Attorney
Dean G. Stathakis
USPTO Deadlines
Next Deadline
2156 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251125)
Due Date
November 25, 2031
Grace Period Ends
May 25, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
45 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 25, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Nov 25, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 4, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Nov 4, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Sep 26, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Sep 25, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 25, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jul 11, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 11, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Mar 20, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jul 11, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 21, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 27, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 27, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Sep 27, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 27, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 23, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 22, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Mar 22, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 22, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 29, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 27, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 27, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 27, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 2, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 28, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 25, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 25, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 25, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 27, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 18, 2022 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| Mar 9, 2022 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Feb 8, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 8, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 19, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 4, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 24, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 24, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 24, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 26, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 26, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 26, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 18, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 17, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 16, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations in chewable tablet dosage form, for the treatment of sleep, cough, cold, and flu, and pain relief; Pharmaceutical preparations, namely, a drug delivery system comprising chewable tablets and polymer-based oral tablets for the release of a wide variety of therapeutic agents; dietary supplements
First Use Anywhere:
Feb 12, 2021
First Use in Commerce:
Sep 22, 2025
Additional Information
Pseudo Mark
LIQUID-TAB
Classification
International Classes
005